The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

Operators and retailers are undertaking FSMA pilots with RFID tags on products packed into cases, which then serves as the ...

Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...

This increase in official controls take place prior to a consignment being cleared for import. When products are exported from the country of origin into another country before coming to Great Britain ...

A division bench of the Delhi High Court comprising of Justice Rekha Palli and Justice Manoj Jain held that reducing employee's pay retrospectively without prior notice and recovering excess ...

Following an inspection of Piramal’s production facility in Maharashtra, India, that ran from Feb. 11 to Feb. 17, the FDA slapped the company with six-observation Form 483 detailing shortfalls ...

According to an FDA official, "The FDA has issued a closure notice to the company. Legal proceedings will be handled by both state and central FDA authorities. The company is currently being ...

The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to ...

Glaukos (GKOS) announced it has received the “Day 74” notification from the U.S. Food and Drug Administration FDA acknowledging the previously submitted New Drug Application NDA for Epioxa Epi ...

the FDA said. The company has been served a show cause notice under the Drugs and Cosmetics Act 1940, and officials have assured that all necessary legal measures will be taken without any delay ...

Some Word forms will not open with Internet Explorer. Use Firefox or choose SAVE AS, not OPEN, to download the file. Read more about downloading Microsoft Office documents. Do not submit your notice ...

Tablet shows same established efficacy and safety as the Evrysdi oral solution. HealthDay News — The U.S. Food and Drug Administration has approved a new drug application for a tablet version of ...